Prospective Randomized Trial Evaluating Mandatory Second Look Surgery With HIPEC and CRS vs. Standard of Care in Subjects at High Risk of Developing Colorectal Peritoneal Metastases.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Antineoplastics
- Indications Cancer metastases; Colorectal cancer
- Focus Therapeutic Use
Most Recent Events
- 02 Jul 2017 Biomarkers information updated
- 16 Mar 2012 Actual end date (Feb 2012) added as reported by ClinicalTrials.gov.
- 16 Mar 2012 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.